Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 12, Pages 1895
Publisher
MDPI AG
Online
2019-11-28
DOI
10.3390/cancers11121895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
- (2019) Wiphawan Wasenang et al. Clinical Epigenetics
- Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
- (2019) Elodie Villa et al. Cancers
- Biological Role and Therapeutic Potential of IDH Mutations in Cancer
- (2018) Matthew S. Waitkus et al. CANCER CELL
- Strelka2: fast and accurate calling of germline and somatic variants
- (2018) Sangtae Kim et al. NATURE METHODS
- MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
- (2018) Jasmine Chong et al. NUCLEIC ACIDS RESEARCH
- Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
- (2018) Hiroaki Fujiwara et al. CANCER SCIENCE
- Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients
- (2018) Keiichi Akahoshi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
- (2018) Eytan M. Stein et al. BLOOD
- Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss
- (2017) Kento Misumi et al. HISTOPATHOLOGY
- Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation
- (2017) Thomas Riffelmacher et al. IMMUNITY
- ACTR-46. AG-120, A FIRST-IN-class MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: UPDATED RESULTS FROM THE PHASE 1 NON-ENHANCING GLIOMA POPULATION
- (2017) Ingo K Mellinghoff et al. NEURO-ONCOLOGY
- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service
- (2017) Angela Hamblin et al. PLOS MEDICINE
- Screening for circulating RAS/RAF mutations by multiplex digital PCR
- (2016) Rikke Fredslund Andersen et al. CLINICA CHIMICA ACTA
- The SWISS-MODEL Repository—new features and functionality
- (2016) Stefan Bienert et al. NUCLEIC ACIDS RESEARCH
- Structure and Functional Characterization of Human Aspartate Transcarbamoylase, the Target of the Anti-tumoral Drug PALA
- (2016) Alba Ruiz-Ramos et al. STRUCTURE
- Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
- (2016) S. K. Saha et al. Cancer Discovery
- Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations
- (2016) Young-Ho Kim et al. Oncotarget
- Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow
- (2016) Zheng Ser et al. Cell Reports
- Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone
- (2015) Ioannis T. Konstantinidis et al. CANCER
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
- (2015) U. E. Emir et al. CANCER RESEARCH
- Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay
- (2015) Alexander Arnold et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma
- (2015) G. Lombardi et al. ONCOLOGIST
- Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis
- (2015) Sergio de Cima et al. Scientific Reports
- Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
- (2014) Rondell P. Graham et al. HUMAN PATHOLOGY
- Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
- (2014) David Malka et al. LANCET ONCOLOGY
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
- (2014) J. S. Ross et al. ONCOLOGIST
- Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer
- (2014) TAKUMI OCHIAI et al. ONCOLOGY REPORTS
- Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases
- (2014) Hanna Tarhonskaya et al. Nature Communications
- Mutational landscape of intrahepatic cholangiocarcinoma
- (2014) Shanshan Zou et al. Nature Communications
- Improved workflows for high throughput library preparation using the transposome-based nextera system
- (2013) Sarah Lamble et al. BMC BIOTECHNOLOGY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
- (2013) Yasuhito Arai et al. HEPATOLOGY
- Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
- (2013) Jesse S. Voss et al. HUMAN PATHOLOGY
- Metabolomics Identifies Pyrimidine Starvation as the Mechanism of 5-Aminoimidazole-4-Carboxamide-1- -Riboside-Induced Apoptosis in Multiple Myeloma Cells
- (2013) C. Bardeleben et al. MOLECULAR CANCER THERAPEUTICS
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids
- (2013) Karen Page et al. PLoS One
- Structure, Functional Characterization, and Evolution of the Dihydroorotase Domain of Human CAD
- (2013) Araceli Grande-García et al. STRUCTURE
- Progress in Ion Torrent semiconductor chip based sequencing
- (2012) Barry Merriman et al. ELECTROPHORESIS
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH
- (2012) J. Rainger et al. HUMAN MOLECULAR GENETICS
- Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia
- (2012) Magdalena Koszarska et al. LEUKEMIA & LYMPHOMA
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- The meaning of p16ink4aexpression in tumors
- (2011) Agnieszka K. Witkiewicz et al. CELL CYCLE
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads
- (2010) G. Lunter et al. GENOME RESEARCH
- Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
- (2010) Nicolas Boissel et al. JOURNAL OF CLINICAL ONCOLOGY
- USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers
- (2010) Shiva Akhavantabasi et al. MAMMALIAN GENOME
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Exome sequencing identifies the cause of a mendelian disorder
- (2009) Sarah B Ng et al. NATURE GENETICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Structures of Human Dihydroorotate Dehydrogenase with and without Inhibitor Reveal Conformational Flexibility in the Inhibitor and Substrate Binding Sites†
- (2008) Björn Walse et al. BIOCHEMISTRY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now